Skip to main content
SpringerLink
Log in

Radiotherapy in the Treatment of Primary Central Nervous System Lymphoma (PCNSL)

  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Abstract

The use of radiotherapy alone to treat primary central nervous system lymphoma (PCNSL) does not produce the high local control and survival rates that it does in limited extranodal non-Hodgkin's lymphoma outside the central nervous system (CNS). Even with doses of whole brain radiation therapy (WBRT) to 40+20 Gy boost, the Radiation Therapy Oncology Group (RTOG) reported a local control rate of 39%. Seventy-nine percent of recurrences were in the 60 Gy region. The median survival was 11.6 months. This response to local radiotherapy is quite different from the response of non-CNS Diffuse Large Cell Lymphoma where doses of 30–40 and >40 Gy have a 75–90% local control rate. Neither systemic lymphoma nor PCNSL have a classic radiotherapy dose response. For PCNSL there appears to be a threshold dose that ranges in the literature between 30 and ≥50 Gy with a median of 40 Gy. Therefore, when radiotherapy is combined with chemotherapy that crosses the BBB, WBRT and/or boost doses may be able to be decreased, especially in patients achieving a complete response. Promising data from the Centre Leon Berard suggest that this is possible. When such chemotherapy was combined with intrathecal chemotherapy and 20 Gy WBRT, they obtained a 56% actuarial 5 year survival rate. Confirmation of single institution reports of favorable results such as these are needed. Cooperative group and intergroup trials are needed to define optimal therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Eby NL, Grufferman S, Flannelly CM, Schold SC, Vogel FS, Burger PC: Increasing incidence of primary brain lymphoma in the U.S. Cancer 62: 2461–2465, 1988

    PubMed  Google Scholar 

  2. Nelson DF, Martz KL, Bonner H, Nelson JS, Newall J, Kerman UD, Thomson JW, Murray KJ: Non-Hodgkin's lymphoma of the brain: can high dose, large volume radiation therapy improve survival? Report on a prospective trial by the Radiation Therapy Oncology Group (RTOG): RTOG 8315. Int J Radiat Oncol Biol Phys 23: 9–17, 1992

    PubMed  Google Scholar 

  3. Schultz C, Scott C, Sherman W, Donahue B, Fields J, Murray K, Fisher B, Abrams R, Meis-Kindblom: Preirradiation chemotherapy with cyclophosphamide, doxorubicin, vincristine, and dexamethasone for primary CNS lymphomas: initial report of Radiation Therapy Oncology Group Protocol 88–06. J Clin Oncol 14: 556–564, 1996

    PubMed  Google Scholar 

  4. O'Neill BP, O'Fallon JR, Earle JD, Colgan JP, Brown LD, Krigel RL: Primary central nervous system non-Hodgkin's lymphoma: survival advantages with combined initial therapy? Int Radiat Oncol Biol Phys 33: 663–673, 1995

    Google Scholar 

  5. Hayakawa T, Takakura K, Abe H, Yoshimoto T, Tanaka R, Sugita K, Kikuchi H, Uozumi T, Hori T, Fukui H, Ushio Y, Nomura K, Matsutani M, Mohri N, Kumanishi T, Aozasa K, Nagashima K: Primary central nervous system lymphoma in Japan: a retrospective, cooperative study by CNSLymphoma Study Group in Japan. J Neuro-Oncol 19: 197–215, 1994

    Google Scholar 

  6. Glass J, Gruber ML, Cher L, Hockberg FH: Preirradiation methotrexate chemotherapy of primary central nervous system lymphoma: long-term outcome. J Neurosurg 81: 188–195, 1994

    PubMed  Google Scholar 

  7. Bessell EM, Graus F, Punt JAG, Firth JL, Hope DT, Moloney AJ, Lopez-Guillermo A, Villa S: Primary non-Hodgkin's lymphoma of the CNS treated with BVAM or CHOD/BVAM chemotherapy before radiotherapy. J Clin Oncol 14: 945–954, 1996

    PubMed  Google Scholar 

  8. Pollack IF, Lunsford LD, Flickinger JC, Dameshe K: Prognostic factors in the diagnosis and treatment of primary central nervous system lymphoma. Cancer 63: 939–947, 1989

    PubMed  Google Scholar 

  9. Jellinger K, Radaskiewicz TH, Slowik F: Primary malignant lymphomas of the central nervous system in man. Acta Neuropath (Berlin) (Suppl VI): 95–102, 1975

  10. Henry JM, Heffner RR, Dillard SH et al.: Primary malignant lymphomas of the central nervous system. Cancer 34: 1293, 1974

    PubMed  Google Scholar 

  11. Gonzalez D, Schuster-Uitterhoeve ALJ: Primary non-Hodgkin's lymphoma of the central nervous system. Results of radiotherapy in 15 cases. Cancer 51: 2048–2052, 1983

    PubMed  Google Scholar 

  12. Laperriere NJ, Cerezo L, Milosevic MF, Shun Wong C, Patterson B, Panzarella T: Primary lymphoma of brain: results of management of a modern cohort with radiation therapy. Radiother Oncol 43: 247–252, 1997

    PubMed  Google Scholar 

  13. Littman P, Wang CC: Reticulum cell sarcoma of the brain. A review of the literature and a study of 19 cases. Cancer 35: 1412–1420, 1975

    PubMed  Google Scholar 

  14. Letendre L, Banks PM, Reese DF, Miller RH, Scanlon PW, Kiely JM: Primary lymphoma of the central nervous system. Cancer 49: 939–943, 1982

    PubMed  Google Scholar 

  15. Mendenhall NP, Thar TL, Agrr OF: Primary lymphoma of the central nervous system. Cancer 52: 1993–2000, 1983

    PubMed  Google Scholar 

  16. Murray K, Kun L, Cox J: Primary malignant lymphoma of the central nervous system. Results of treatment of 11 cases and review of the literature. J Neurosurg 65: 600–607, 1986

    PubMed  Google Scholar 

  17. Rampen FHJ, van Andel JG, Sizoo W, van Unnik JAM: Radiation therapy in primary non-Hodgkin's lymphomas of the CNS. Eur J Cancer 16: 177–184, 1980

    PubMed  Google Scholar 

  18. Berry MP, Simpson WJ: Radiation therapy in the management of primary malignant lymphoma of the brain. Int J Radiat Oncol Biol Phys 7: 755–759, 1981

    PubMed  Google Scholar 

  19. Sagerman RH, Cassady JR, Chang CH: Radiation therapy for intracranial lymphoma. Radiology 88: 552–554, 1967

    PubMed  Google Scholar 

  20. Sagerman RH, Collier CH, King GA: Radiation therapy of microgliomas. Radiology 149: 567–570, 1983

    PubMed  Google Scholar 

  21. Blay JY, Bouhour D, Carrie C, Bouffet F, Brunat-Mentigny M, Philip T, Biron P: The C5R protocol: a regimen of high-dose chemotherapy and radiotherapy in primary cerebral non-Hodgkin's lymphoma of patients with no known cause of immunosuppression. Blood 86: 2922–2929, 1995

    PubMed  Google Scholar 

  22. DeAngelis LM, Yahalom J, Thaler HT, Kher U: Combined modality therapy for primary CNS lymphoma. J Clin Oncol 10: 635–643, 1992 247

    PubMed  Google Scholar 

  23. Newalt EA, Goldman DL, Dahlborg SA: Primary CNS lymphoma treated with osmotic blood brain barrier disruption: prolonged survival and preservation of cognitive function. J Clin Oncol 9: 1580–1590, 1991

    PubMed  Google Scholar 

  24. Chen MG, Prosnitz LR, Gonzalez-Serva A, Fischer DB: Results of radiotherapy in control of stage I and II non-Hodgkin's lymphoma. Cancer 43: 1245–1254, 1979

    PubMed  Google Scholar 

  25. Fraser RW, Chism SF, Stern R, Fu KK, Buschke F: Clinical course of early extranodal non-Hodgkin's lymphomas. Int J Radiat Oncol Biol Phys 11: 177–183, 1985

    Google Scholar 

  26. Horiuchi J, Okuyama T, Matsubara S, Shibuya H, Suzuki S, Kamiyama R: Extranodal non-Hodgkin's lymphoma in the head and neck. Irradiation and clinical course. Acta Radiol Oncol 21: 393–399, 1982

    PubMed  Google Scholar 

  27. Jacobs C, Hoppe RT: Non-Hodgkin's lymphomas of head and neck extranodal sites. Int J Radiat Oncol Biol Phys 11: 357–364, 1985

    PubMed  Google Scholar 

  28. Mill WB, Lee FA, Franssila KO: Radiation therapy treatment of stage I and II extranodal non-Hodgkin's lymphoma of the head and neck. Cancer 45: 653–661, 1980

    PubMed  Google Scholar 

  29. Shirato H, Tsujii H, Arimoto T, Miiyamoto M, Azumi N, Nojima T, Watanbe S, Illie G: Early stage head and neck non-Hodgkin's lymphoma. The effect of tumor burden on prognosis. Cancer 58: 2312–2319, 1986

    PubMed  Google Scholar 

  30. Teshima T, Chatani M, Hata K, Inoue T, Miyahara H, Sato T, Shibata H, Kusakabe H, Tateishi R, SuzukiT: Radiation therapy for primary non-Hodgkin's lymphoma of the head and neck in stage I-II. Strahlenther Onkol 162: 478–483, 1986

    PubMed  Google Scholar 

  31. Wulfrank D, Speelman T, Pauwels C, Roels H, DeSchryver A: Extranodal non-Hodgkin's lymphoma of the head and neck. Radiother Oncol 8: 199–207, 1987

    PubMed  Google Scholar 

  32. Fuks Z, Kaplan HS: Recurrence rates folowing radiation therapy of nodular and diffuse malignant lymphomas. Radiology 108: 675–684, 1973

    PubMed  Google Scholar 

  33. Cox JD, Koehl RH, Turner WM, King FM: Irradiation in the local control of malignant lymphoreticular tumors (non-Hodgkin's malignant lymphoma). Radiology 112: 179–185, 1974.

    PubMed  Google Scholar 

  34. Bush RS, Gospodarowicz M: The place of radiation therapy in the management of patients with localized non-Hodgkin's lymphoma. In: Rosen SA, Kaplan HS (<nt>eds</nt>) Malignant Lymphomas. Academic Press, Orlando, pp. 485–502, 1982.

    Google Scholar 

  35. Loeffler JS, Ervin TJ, Mauch P: Primary lymphomas of the central nervous system: patterns of failure and factors that influence survival. J Clin Oncol 3: 490–494, 1985

    PubMed  Google Scholar 

  36. Hochberg FH: Chemotherapy alone in the treatment of PCNSL, presented at the International Primary Central Nervous System Lymphoma Meeting, Tubingen, Germany, 1997 (published this issue)

    Google Scholar 

  37. De Angelis LM: Radiochemotherapy in the treatment of PCNSL, presented at the International Primary Central Nervous System Lymphoma Meeting, Tubingen, Germany, 1997 (published this issue)

    Google Scholar 

  38. Cox JD, Koehl RH, Turner WM, King FM: Irradiation in the local control of malignant lymphoreticular tumors (non-Hodgkin's malignant lymphoma). Radiology 112: 179–185, 1974.

    PubMed  Google Scholar 

  39. Ott RJ, Brada M, Flower MA, Babich JW, Cherry SR, Deehan BJ: Measurements of blood-brain barrier permeability in patients undergoing radiotherapy and chemotherapy for primary cerebral lymphoma. Eur J Cancer 27: 1356–1361, 1991 </del>

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Radiation Oncology, Mayo Clinic, Rochester, MN, USA

    Diana Furst Nelson

Authors
  1. Diana Furst Nelson
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nelson, D.F. Radiotherapy in the Treatment of Primary Central Nervous System Lymphoma (PCNSL). J Neurooncol 43, 241–247 (1999). https://doi.org/10.1023/A:1006206602918

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1006206602918

Search

Navigation